id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-03-11 22:35:38
expired found date
-
created at
2024-06-05 06:35:42
updated at
2026-01-04 09:44:04
length
14
crc
53365
tld
2644
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
81149
mp size raw text
3937
mp inner links count
4
mp inner links status
20 (imported)
title
Author Insight, Press Releases and Event News by Oncotarget | Oncotarget.net
description
Hear from the distinguished network of authors who publish their research with Oncotarget, plus information on company news and events sponsored by Oncotarget.
site name
Oncotarget
author
updated
2025-12-15 23:47:35
raw text
Author Insight, Press Releases and Event News by Oncotarget | Oncotarget.net Skip to the content Search Oncotarget Menu Welcome News Search Generic selectors Exact matches only Search in title Search in content Post Type Selectors post page Close search Close Menu Welcome News Oncotarget Oncotarget AUTHOR INSIGHT, COMMUNITY NEWS & EVENTS BY ONCOTARGET: Oncotarget at AACR Annual Meeting 2024 March 11, 2024 Oncotarget is proud to participate at the American Association for Cancer Research (AACR) Annual Meeting 2024, which convenes April 5-10 in San Diego, California. GZ17-6.02 With Proteasome Inhibitors Kills Multiple Myeloma Cells March 6, 2024 PRESS RELEASE: On March 5, 2024, a new research paper was published in Oncotarget, entitled, “GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells.” Sacituzumab Govitecan Plus Platinum-based Chemotherapy in Breast, Bladder, and Lung...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025110801
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
3083
text words
538
text unique words
272
text lines
88
text sentences
27
text paragraphs
10
text words per sentence
19
text matched phrases
4
text matched dictionaries
2
links self subdomains
0
links other subdomains
0
links other domains
8 - oncotarget.com, oncotarget.org, impactjournals.com, scientificamerican.com, mikhailblagosklonny.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
1
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
10 - static.addtoany.com, twitter.com, facebook.com, instagram.com, youtube.com, linkedin.com, pinterest.com, reddit.com, wordpress.org
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-15 23:47:35
rss path
rss status
32 (unknown)
rss found date
2024-03-21 12:08:06
rss size orig
108182
rss items
50
rss spam phrases
0
rss detected language
1 (English)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
111
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-03-21 00:43:36
sitemap process date
2025-05-06 18:21:32
sitemap first import date
-
sitemap last import date
2026-01-04 09:44:04